ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: FR-PO794

Longitudinal Analysis of Donor-Derived Cell-Free DNA (dd-cfDNA) in En Bloc Kidney Transplantation

Session Information

Category: Transplantation

  • 2002 Transplantation: Clinical


  • Akkina, Sanjeev, Loyola University Chicago, Chicago, Illinois, United States
  • Singh, Neeraj, Willis-Knighton Health System, Shreveport, Louisiana, United States
  • Klein, Jeffrey A., University of Kansas School of Medicine, Kansas City, Kansas, United States
  • Agrawal, Nikhil, CareDx Inc, Brisbane, California, United States
  • Fei, Mingwei, CareDx Inc, Brisbane, California, United States
  • Desai, Amishi S., Loyola University Chicago, Chicago, Illinois, United States

The longitudinal dd-cfDNA patterns in en-bloc kidney transplant recipients have not been studied. It is unknown how the initial smaller mass of the two pediatric organs impacts ddcfDNA early post-transplant or if the dd-cfDNA rises over time as the organs enlarge. We analyzed ddcfDNA scores over thefirst 12 months in recipients of pediatric en-bloc kidneys enrolled in the Kidney allograft Outcomes AlloSure Registry (KOAR, NCT03326076).


16 recipients of pediatric en-bloc kidneys with donors aged ≤7 years old were identified and compared with 931 single, non en-bloc deceased donorrecipients. Patients with rejection were excluded.


Of the 16 en-bloc recipients, 56.2% were male with median donor age of 1.4 years and median cold ischemia time (CIT) of 20 hours. None of the en-bloc transplants had delayed graft function. Aside from KDPI, donor age, and recipient age, no other differences were observed between groups.
Higher median ddcfDNA values were seen in the en-bloc cohort compared to not en-bloc at month 1 (M1, 1.4% vs 0.4%) and month 2 (0.58% vs 0.23%) after transplant (p<0.001) [Figure 1a]. Median ddcfDNA values were comparable for month 3 (0.21% vs 0.16%, p = 0.07) and all subsequent time points. [Figure 1a,1b]. Among 8 patients with M1 ddcfDNA results, there was no significant association between M1 ddcfDNA and either CIT (r=0.33, p=0.419) or KDPI (r=0.23,p=0.589).


Our results demonstrate higher early post-transplant ddcfDNA values among en-bloc kidney compared to single kidney recipients however, no difference or upward trend is observed beyond month 2 and out to 12 months.


  • Commercial Support